
Monteloeder launches BeRelief: a new botanical ingredient for musculoskeletal pain relief
Nutraceutical developer Monteloeder explained the research and development of its new ingredient, supported by a recent clinical study.
In a July 30, 2024
Research for developing BeRelief involved assessing 50,000 natural compounds and selecting ones based on their molecular interactions with receptors involved in the perception of discomfort and pain.
"As a research-driven company, we are inspired by nature and traditional herbal medicine to create botanical solutions that can help people feel better," stated Maria Ángeles Gutiérrez Montero, Marketing Director of SuanNutra, in the press release. "We are combining the wisdom of Eastern botanical medicine with modern science and 'big data' to support this innovative solution and provide a holistic approach to total well-being."
The ingredient was developed with the assistance of machine learning, and was also tested in a randomized double-blind controlled study, which was recently published in Frontiers in Nutrition1. The 12-week trial involved 135 participants with back and neck pain. Two groups of the participants received doses of BeRelief – either 400mg or 800mg – and both demonstrated a reduction in their discomfort, by 56% in the group with the lower dose and by 59% in the group with the higher dose. The relief was reported to be sustained, and BeRelief users also reported improved mood and sleep.
"Discomfort and soreness can be debilitating and significantly impact a person's quality of life," explained Gutiérrez Montero. "Developing a natural ingredient can help enhance quality of life by reducing or alleviating pain. In today's sedentary, stress-filled, and sleep-deprived lifestyles, discomfort and pain are increasingly common. Prolonged sitting, repetitive activities, occasional stress peaks, and lack of sleep can lead to issues like muscle tension, joint pain, and headaches, which worsen over time."
Support for the development of BeRelief came from Center for Technological Development and Innovation (CDTI Innovation) and was financed in part by the European Union's FEDER funds.
Reference
- Pérez-Piñero, S., Muñoz-Carrillo, J. C., Echepare-Taberna, J., Luque-Rubia, A. J., Millán Rivero, J. E., Muñoz-Cámara, M., Díaz Silvente, M. J., Valero Merlos, E., Ávila-Gandía, V., Caturla, N., Navarro, P., Cabrera, M., & López-Román, F. J. Dietary supplementation with plant extracts for amelioration of persistent myofascial discomfort in the cervical and back regions: A randomized double-blind controlled study. Frontiers in Nutrition, 2024, 11. DOI:
10.3389/fnut.2024.1403108
Newsletter
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.





